SCHEMBL30762866

SCHEMBL30762866

CC(C)OC(=O)C(C)Oc1ccc2c(-c3ccccc3Br)cc(=O)oc2c1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.58
▸ HPGD P15428 9/20 0.58
▸ ALDH2 P05091 1/20 0.52
▸ KDM4E B2RXH2 4/20 0.51
▸ RECQL P46063 2/20 0.51
▸ AR P10275 1/20 0.49
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.46
▸ RAB9A P51151 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ IGLV6-57 P01721 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ CA9 Q16790 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839047 1.00 ALDH1A1 (0.58) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL30762942 0.88 ALDH1A1 (0.62) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL20839471 0.88 ALDH1A1 (0.62) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL22431787 0.88 ALDH1A1 (0.59) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL30056759 0.88 ALDH1A1 (0.59) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL20839174 0.88 ALDH1A1 (0.59) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL26503495 0.88 ALDH1A1 (0.59) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL20839176 0.88 ALDH1A1 (0.59) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL26106000 0.88 ALDH1A1 (0.75) ALDH1A1HPGDALDH2KDM4ERECQL
SCHEMBL21629592 0.86 ALDH1A1 (0.79) ALDH1A1HPGDALDH2KDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback